A prospective, open-label, 2-period, fixed-sequence study of drug drug interaction between rifampicin (single dose and multiple dose) with doravirine in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 28 Mar 2017
At a glance
- Drugs Doravirine (Primary) ; Rifampicin (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 28 Mar 2017 Results (n=10) published in the Clinical Drug Investigation.
- 28 Aug 2015 New trial record